Correction to: Signal Transduction and Targeted Therapy https://doi.org/10.1038/s41392-020-00416-z, published online 13 February 2021
In the process of collating the published data, the authors noticed one inadvertent mistake occurred during the production process in Fig. 1u that needs to be corrected.1 The authors mistakenly placed the wrong western blot figure for the level of pTauS404 in the urea fraction of mice from the onset cohort in Fig. 1u. The correct data are provided as follows. The key findings of the article are not affected by these corrections. The original article has been corrected.
(u) Levels of human Tau (stained with HT7 antibody), pTauS202/T205 (stained with AT8 antibody), pTauS396 (stained with PHF13 antibody), and pTauS404 in the brain homogenates of mice from the onset cohorts after vaccination assessed by western blot assay. GAPDH served as the internal control. The orange arrowheads indicated the Tau or pTau band. The blue arrowheads indicated the GAPDH band. The relative content of each sample was marked under ladders
Reference
Sun, Y. et al. Norovirus P particle-based tau vaccine-generated phosphorylated tau antibodies markedly ameliorate tau pathology and improve behavioral deficits in mouse model of Alzheimer’s disease. Signal Transduct. Target. Ther. 6, 2020–2022 (2021).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Sun, Y., Guo, Y., Feng, X. et al. Correction to: Norovirus P particle-based tau vaccine-generated phosphorylated tau antibodies markedly ameliorate tau pathology and improve behavioral deficits in mouse model of Alzheimer’s disease. Sig Transduct Target Ther 6, 237 (2021). https://doi.org/10.1038/s41392-021-00657-6
Published:
DOI: https://doi.org/10.1038/s41392-021-00657-6
